Anti-Rheumatics Market Major Competitors, Regional Segments, Strategies and Forecast 2030

According to a new market research report published by Inkwood Research, the Global Anti-Rheumatics Market is estimated to record a CAGR of 2.32% during the forecasting years of 2020-2028.
"Browse 31 Market Data Tables and 38 Figures spread over 150 Pages, along with an in-depth TOC on the Global Anti-Rheumatics Market Forecast 2020-2028."

REQUEST CUSTOMIZATION LINK- https://www.inkwoodresearch.com/request-for-custom-report/

REQUEST FREE SAMPLE LINK- https://www.inkwoodresearch.com/reports/anti-rheumatics-market/#request-free-sample

VIEW TABLE OF CONTENT LINK- https://www.inkwoodresearch.com/reports/anti-rheumatics-market/#table-of-contents

BUY NOW- https://www.inkwoodresearch.com/reports/anti-rheumatics-market/
Rheumatoid arthritis is a chronic inflammatory medical condition that causes swollen and painful joints in patients. RA is an autoimmune disorder, which means the body's immune system attacks its own tissues. The drugs used for the treatment of rheumatoid arthritis are known as anti-rheumatics. For example, DMARDs, NSAIDs, corticosteroids, and others are various types of drugs used for treating rheumatoid arthritis. DMARDs improve the course of action, and NSAIDs act on pain. The factors fueling the growth of the market are a surge in the elderly population across the world, a rise in incidences of obesity worldwide, and an increase in awareness related to early screening and treatment of RA.

Rising Elderly Population across the Globe Propels Market Growth
The global geriatric population has increased rapidly and is prone to rheumatoid arthritis. In 2017, as per the world population aging report, the global population aged 60 years or above was 962 million, which is more than twice the number of 382 million in 1980. By 2050, the number of older people is expected to double again and reach 2.1 million. The number of people aged 80 or above, which is 137 million, is estimated to increase three times to 425 million between 2017- 2050. Two-thirds of the world's older people live in developing countries, and their number is growing faster in developing nations than the developed countries.
To know more about this report, request a free sample copy.

Prescription-Based Drugs Holds the Largest Market Share in the Type Segment
Prescription-based drugs need a medical prescription for dispensation. These help the patients to get the correct dose of the drug without any side effects during the treatment of rheumatoid arthritis. Disease-modifying anti-rheumatic (DMARDs) and uric acid drugs are the most common among prescribed medicines, and some other anti-rheumatics include Humira, Enbrel, and Cimzia.

North America Predicted to Record the Highest CAGR
The region of North America is anticipated to record the highest growth during the forecast period, due to a rise in the prevalence of rheumatoid arthritis, and the growing geriatric population. Further, the presence of well-known players, like Merck & Co. Inc, Bristol-Myers Squibb Company, Amgen Inc, Pfizer, Inc, AbbVie Inc, and Eli Lilly Company is making the market look promising.
The competitive rivalry is high in the anti-rheumatics market, due to the presence of similar products offered by many companies. Hence, the companies have to adopt strategies such as the expansion of portfolio, geographies, and intensive R&D to maintain their position in the market. The eminent market players operating the market include, Eli Lilly & Company, AbbVie Inc, UCB, Pfizer Inc, etc.

Related Report:
GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET
GLOBAL BONE GRAFT AND SUBSTITUTE MARKET
GLOBAL BONE DENSITOMETER MARKET

169, Harrison Avenue
Boston, MA 02111
Tel: 1-(857)293-0150
Email: sales@inkwoodresearch.com
Website: www.inkwoodresearch.com

We at Inkwood research provide you with not just consulting services but also with syndicated and customized research reports which help advance your business further.

This release was published on openPR.